Evidence has shown that miR‐222‐3p could target several genes, and a relationship of miR‐222‐3p‐targeted CDKN1B has been implicated in breast cancer cells 29 and vascular smooth muscle cells 30, but this relationship has not been reported in NP cells. The gene discussed is CDKN1B; the disease is breast carcinoma.